:
Triazavirin (2-methylsulfanyl-6-nitro[1,2,4]triazolo[5,1-c][1,2,4]triazin-7(4H)-one, TZV) is an antiviral drug
synthesized. TZV is being investigated for potential application against the Coronavirus 2019-nCoV. In order to find
candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug
Triazavirin (C5H4N6O3S) which may work as inhibitor for the Mpro of 2019-nCoV. In the present work, first time the
molecular structure of title molecule has been investigated using Density Functional Theory (DFT/B3LYP/MidiX) in gas
phase. The molecular HOMO-LUMO, excitation energies and oscillator strengths of investigated compound have also
been calculated and presented. The interaction of TZV compound with the Coronavirus was performed by molecular
docking studies. Therefore, TZV can be used for potential application against the Coronavirus 2019-nCoV.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.